Add to ORKGSuccessful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
BACKGROUND: For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery i...
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity o...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
Background and aims Survival rates of patients with stage IV melanoma are poor: Median survival is 7...
Hypothesis :The clinical treatment of patients with stage IV melanoma according to criteria of the A...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Although previously the mainstay of treatment, the role of surgery in the management of patients wit...
Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient tre...
BACKGROUND: Although resection historically played a prominent role in the treatment of metastatic m...
BACKGROUND: On the basis of retrospective experience at individual centers, it appears that patient...
Stage IV melanoma has historically had a poor prognosis because of lack of responsiveness to traditi...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
BACKGROUND: For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery i...
Successful systemic management of stage IV melanoma continues to be elusive because of the paucity o...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
In melanoma, about 1 in 5 patients develops distant metastases and suffers a very poor prognosis. Co...
Background and aims Survival rates of patients with stage IV melanoma are poor: Median survival is 7...
Hypothesis :The clinical treatment of patients with stage IV melanoma according to criteria of the A...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Opportunities for surgical treatment in metastatic melanoma patients have re-emerged due to the deve...
Although previously the mainstay of treatment, the role of surgery in the management of patients wit...
Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient tre...
BACKGROUND: Although resection historically played a prominent role in the treatment of metastatic m...
BACKGROUND: On the basis of retrospective experience at individual centers, it appears that patient...
Stage IV melanoma has historically had a poor prognosis because of lack of responsiveness to traditi...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery is considered...
BACKGROUND: For stage IV melanoma, systemic medical therapy (SMT) is used most frequently; surgery i...